Stay updated with breaking news from Short s supply. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
flaws. indeed there s none who is righteous, no not one as the good book teaches. then we went through a phase where we wanted someone we could relate to, someone likable, someone we wouldn t mind sharing a drink or a meal with. being fun or likable is not the same as being competent. we don t pick a neurosurgeon based on how fun he or she is at a cocktail party. we don t pick an accountant based on his or her sense of humor. we pick the person with the most talent and experience and character and ability, the person who would be the most competent at doing the job. now it seems our politics leans towards someone who captures our frustration, our angst, disappointment, anger, and fear, someone who can list the grievances, someone who provides a reflection of where we are, but not necessarily where we should be heading. do we really need someone to tell us where we are? wouldn t we be better served with someone telling us how to get where we want to go. as we reflect on ....
Five-year record with about 200 medications, critical medications listed in short s supply. bottom line, trey, when it comes to pharmaceutical industry, it is complex. the research and development isb extremeloty expensive, and thene actually get the drug from the lab to the patient is nothing short of a labyrinth. we can really point the blame al you have chronic vulnerabilities and acute disruptions. one of the biggest examples is what we just saw with baby ch formula shortage in the last year. you had fda shut down abbott manufacturing and didn t have at plan as to h get abbott back upt all of a sudden, the country way short of baby formula. that s huge. when it comes to our regulatorye they are inefficient and lack of transparency, but also a really big chronic vulnerability that we have was exacerbated during the obama era with his globalization movement. now you have about 90 percent of raw materials for all pharmaceutical manufacturing isf produced iacn china and india. ....